Martine Bot

1.5k total citations
23 papers, 1.1k citations indexed

About

Martine Bot is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Martine Bot has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Immunology and 6 papers in Surgery. Recurrent topics in Martine Bot's work include Sphingolipid Metabolism and Signaling (7 papers), Atherosclerosis and Cardiovascular Diseases (4 papers) and Cholesterol and Lipid Metabolism (4 papers). Martine Bot is often cited by papers focused on Sphingolipid Metabolism and Signaling (7 papers), Atherosclerosis and Cardiovascular Diseases (4 papers) and Cholesterol and Lipid Metabolism (4 papers). Martine Bot collaborates with scholars based in Netherlands, Germany and United States. Martine Bot's co-authors include Erik A.L. Biessen, Ilze Bot, Theo J.C. van Berkel, Saskia C.A. de Jager, Johan Kuiper, Theo van Berkel, Horst Robenek, Georg Varga, Carsten Müller‐Tidow and Jerzy–Roch Nofer and has published in prestigious journals such as Circulation, The Journal of Experimental Medicine and PLoS ONE.

In The Last Decade

Martine Bot

22 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Martine Bot Netherlands	16	534	478	227	214	174	23	1.1k
Marco Cattaruzza Germany	19	382 0.7×	241 0.5×	102 0.4×	306 1.4×	78 0.4×	36	1.1k
Karrie L. Jones United States	15	513 1.0×	310 0.6×	95 0.4×	353 1.6×	121 0.7×	20	1.2k
K. Nguyen United States	7	324 0.6×	264 0.6×	87 0.4×	351 1.6×	142 0.8×	10	1.3k
Curran Murphy United States	8	594 1.1×	344 0.7×	171 0.8×	119 0.6×	32 0.2×	12	1.2k
Yuko Takeba Japan	19	342 0.6×	227 0.5×	106 0.5×	85 0.4×	133 0.8×	48	946
Petri Laine Finland	11	181 0.3×	515 1.1×	154 0.7×	111 0.5×	86 0.5×	14	865
Laura S. Shankman United States	14	943 1.8×	702 1.5×	208 0.9×	115 0.5×	33 0.2×	17	1.6k
Per Antonson Sweden	22	783 1.5×	329 0.7×	181 0.8×	158 0.7×	37 0.2×	39	1.5k
Yajun Feng United States	10	537 1.0×	189 0.4×	130 0.6×	314 1.5×	32 0.2×	13	1.1k
Lucia Centurione Italy	20	551 1.0×	252 0.5×	121 0.5×	198 0.9×	60 0.3×	50	1.2k

Countries citing papers authored by Martine Bot

Since Specialization

Citations

This map shows the geographic impact of Martine Bot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martine Bot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martine Bot more than expected).

Fields of papers citing papers by Martine Bot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martine Bot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martine Bot. The network helps show where Martine Bot may publish in the future.

Co-authorship network of co-authors of Martine Bot

This figure shows the co-authorship network connecting the top 25 collaborators of Martine Bot. A scholar is included among the top collaborators of Martine Bot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martine Bot. Martine Bot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bot, Martine, Jacky Flipse, Suzanne Bongers, et al.. (2025). Diagnostic characteristics of the Rapid ESBL NP® test and ResistanceFinder 2SMART multiplex PCR for the detection of ESBL directly on urine samples. European Journal of Clinical Microbiology & Infectious Diseases. 44(12). 3021–3028.

Bot, Ilze, Han Jin, Aimée J P M Franssen, et al.. (2019). Low human and murine Mcl-1 expression leads to a pro-apoptotic plaque phenotype enriched in giant-cells. Scientific Reports. 9(1). 14547–14547. 5 indexed citations

Ellenbroek, Guilielmus H.J.M., Gijs H.M. van Puijvelde, Adam A. Anas, et al.. (2017). Leukocyte TLR5 deficiency inhibits atherosclerosis by reduced macrophage recruitment and defective T-cell responsiveness. Scientific Reports. 7(1). 42688–42688. 17 indexed citations

Temmerman, Lieve, Ilze Bot, Bart J.M. van Vlijmen, et al.. (2017). Leukocyte Bim deficiency does not impact atherogenesis in ldlr −/− mice, despite a pronounced induction of autoimmune inflammation. Scientific Reports. 7(1). 3086–3086. 5 indexed citations

Lagraauw, H. Maxime, Martine Bot, Anouk Wezel, et al.. (2014). Vascular neuropeptide Y contributes to atherosclerotic plaque progression and perivascular mast cell activation. Atherosclerosis. 235(1). 196–203. 31 indexed citations

Bot, Martine, Saskia C.A. de Jager, Luke MacAleese, et al.. (2013). Lysophosphatidic acid triggers mast cell-driven atherosclerotic plaque destabilization by increasing vascular inflammation. Journal of Lipid Research. 54(5). 1265–1274. 60 indexed citations

Bot, Martine, Paul P. Van Veldhoven, Saskia C.A. de Jager, et al.. (2013). Hematopoietic Sphingosine 1-Phosphate Lyase Deficiency Decreases Atherosclerotic Lesion Development in LDL-Receptor Deficient Mice. PLoS ONE. 8(5). e63360–e63360. 24 indexed citations

Jager, Saskia C.A. de, Ilze Bot, Adriaan O. Kraaijeveld, et al.. (2013). Leukocyte-Specific CCL3 Deficiency Inhibits Atherosclerotic Lesion Development by Affecting Neutrophil Accumulation. Arteriosclerosis Thrombosis and Vascular Biology. 33(3). e75–83. 55 indexed citations

Bot, Ilze, Henk de Vries, Suzanne J.A. Korporaal, et al.. (2012). Adenosine A _2B Receptor Agonism Inhibits Neointimal Lesion Development After Arterial Injury in Apolipoprotein E–Deficient Mice. Arteriosclerosis Thrombosis and Vascular Biology. 32(9). 2197–2205. 22 indexed citations

10.

Calpe‐Berdiel, Laura, Ying Zhao, Marjo de Graauw, et al.. (2012). Macrophage ABCA2 deletion modulates intracellular cholesterol deposition, affects macrophage apoptosis, and decreases early atherosclerosis in LDL receptor knockout mice. Atherosclerosis. 223(2). 332–341. 13 indexed citations

11.

Potì, Francesco, Martine Bot, Sara Costa, et al.. (2012). Sphingosine kinase inhibition exerts both pro- and anti-atherogenic effects in low-density lipoprotein receptor-deficient (LDL-R−/−) mice. Thrombosis and Haemostasis. 107(3). 552–561. 24 indexed citations

12.

Bock, Hans H., Thomas Engel, Ralph Telgmann, et al.. (2011). Apolipoprotein E Induces Antiinflammatory Phenotype in Macrophages. Arteriosclerosis Thrombosis and Vascular Biology. 31(5). 1160–1168. 261 indexed citations

13.

Yu, Haixiang, Ilze Bot, Xingfu Xu, et al.. (2011). Selective Modulation of Nuclear Factor of Activated T-Cell Function in Restenosis by a Potent Bipartite Peptide Inhibitor. Circulation Research. 110(2). 200–210. 6 indexed citations

14.

Bot, Martine, Ilze Bot, Rubén López‐Vales, et al.. (2010). Atherosclerotic Lesion Progression Changes Lysophosphatidic Acid Homeostasis to Favor its Accumulation. American Journal Of Pathology. 176(6). 3073–3084. 55 indexed citations

15.

Bot, Ilze, Martine Bot, Sandra H. van Heiningen, et al.. (2010). Mast cell chymase inhibition reduces atherosclerotic plaque progression and improves plaque stability in ApoE−/− mice. Cardiovascular Research. 89(1). 244–252. 56 indexed citations

16.

Bot, Ilze, Saskia C.A. de Jager, Martine Bot, et al.. (2009). Short Communication: The Neuropeptide Substance P Mediates Adventitial Mast Cell Activation and Induces Intraplaque Hemorrhage in Advanced Atherosclerosis. Circulation Research. 106(1). 89–92. 57 indexed citations

17.

Telgmann, Ralph, et al.. (2008). Abstract 1727: Apolipoprotein E (ApoE) Induces an Anti-inflammatory Phenotype in Macrophages. Circulation. 118(suppl_18). 1 indexed citations

18.

Nofer, Jerzy–Roch, Martine Bot, Martin F. Brodde, et al.. (2007). FTY720, a Synthetic Sphingosine 1 Phosphate Analogue, Inhibits Development of Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice. Circulation. 115(4). 501–508. 187 indexed citations

19.

Bot, Martine, Jerzy–Roch Nofer, T J van Berkel, & Erik A.L. Biessen. (2007). Lysophospholipids: Two-Faced Mediators In Atherosclerosis. 2(3). 341–356. 3 indexed citations

20.

Hart, Leen M. ‘t, Timon W. van Haeften, Joost Dekker, et al.. (2002). Variations in Insulin Secretion in Carriers of the E23K Variant in the KIR6.2 Subunit of the ATP-Sensitive K+ Channel in the β-Cell. Diabetes. 51(10). 3135–3138. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact